Liminatus Pharma, Inc. (LIMN)
3.78
+0.09
(+2.44%)
USD |
NASDAQ |
Oct 09, 16:00
3.78
0.00 (0.00%)
After-Hours: 20:00
Liminatus Pharma Price to Book Value : 0.2817 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 0.275 |
| October 07, 2026 | 0.2891 |
| October 06, 2026 | 0.2757 |
| October 05, 2026 | 0.2973 |
| October 02, 2026 | 0.2906 |
| October 01, 2026 | 0.2794 |
| September 30, 2026 | 0.278 |
| September 29, 2026 | 0.2914 |
| September 28, 2026 | 0.3182 |
| September 25, 2026 | 0.3126 |
| September 24, 2026 | 0.3115 |
| September 23, 2026 | 0.3003 |
| September 22, 2026 | 0.3033 |
| September 21, 2026 | 0.2712 |
| September 18, 2026 | 0.2593 |
| September 17, 2026 | 0.2526 |
| September 16, 2026 | 0.2481 |
| September 15, 2026 | 0.2616 |
| September 14, 2026 | 0.2623 |
| September 11, 2026 | 0.2586 |
| September 10, 2026 | 0.2705 |
| September 09, 2026 | 0.2593 |
| September 08, 2026 | 0.2698 |
| September 04, 2026 | 0.2765 |
| September 03, 2026 | 0.2757 |
| Date | Value |
|---|---|
| September 02, 2026 | 0.2861 |
| September 01, 2026 | 0.2716 |
| August 31, 2026 | 0.2876 |
| August 28, 2026 | 0.3152 |
| August 27, 2026 | 0.3279 |
| August 26, 2026 | 0.3286 |
| August 25, 2026 | 0.3435 |
| August 24, 2026 | 0.348 |
| August 21, 2026 | 0.3845 |
| August 20, 2026 | 0.4195 |
| August 19, 2026 | 0.4162 |
| August 18, 2026 | 0.4844 |
| August 17, 2026 | 0.5268 |
| August 14, 2026 | 0.5216 |
| August 13, 2026 | 0.5585 |
| August 12, 2026 | 0.4043 |
| August 11, 2026 | 0.4154 |
| August 10, 2026 | 0.4359 |
| August 07, 2026 | 0.3838 |
| August 06, 2026 | 0.3685 |
| August 05, 2026 | 0.3912 |
| August 04, 2026 | 0.4404 |
| August 03, 2026 | 0.4236 |
| July 31, 2026 | 0.3838 |
| July 30, 2026 | 0.3804 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.96 |
| Anika Therapeutics, Inc. | 1.909 |
| Savara, Inc. | 7.042 |
| Vericel Corp. | 5.544 |
Price to Book Value Related Metrics
| Price | 3.78 |
| Earnings Yield | -28.41K% |
| Market Cap | 0.0847M |